Back to Newsroom

Russo Partners Teams with Medovex to Highlight Medical Technology Innovation with DenerveX System for Treatment of Chronic Back Pain

NFL Broadcaster, Agency’s Sports-Health Alliance Leader Solomon Wilcots Kicks Off Campaign with Surgeon Interviews at International Spine Meetings

NEW YORKNov. 13, 2017 /PRNewswire/ — Russo Partners LLC and Medovex Corp. (NASDAQ: MDVX) have teamed to call attention to the need for new treatments for chronic back pain and the Company’s innovative solution known as the DenerveX® System. Currently approved for use outside of the U.S., DenerveX is a new device designed to enable doctors to provide patients with enduring relief of back pain caused by Facet Joint Syndrome.

Click For More Info